Amongst these, HER2-postive MDA-MB-453 and triple-positive ZR-75-1 breast cancer cells showed 36.2% and 54.3% cell death when treated with 1 μg/ml RCFE for 48 hr (Supplementary Fig S1). This evidence concerns the gene ERBB2 and breast carcinoma.